OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
32
Results
Show all
Save search
Copy query
Show results for
Unknown
(32)
Publication Date
Release Date
2018
(29)
2025
(1)
2023
(1)
2020
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
A new ergasilid copepod from lates perches in East Africa: morphology, phylogenetics, and genetic structure of <i>Ergasilus ereimia</i> sp. nov.
Not available
S-EPMC12908592
|
biostudies-literature
Cite
An updated nuclear-physics and multi-messenger astrophysics framework for binary neutron star mergers.
Not available
S-EPMC10733434
|
biostudies-literature
Cite
Whole genome sequence analysis of pulmonary function and COPD in 19,996 multi-ethnic participants.
Not available
S-EPMC7598941
|
biostudies-literature
Cite
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples.
Not available
S-EPMC5890960
|
biostudies-literature
Cite
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
Not available
S-EPMC5959730
|
biostudies-literature
Cite
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily.
Not available
S-EPMC6370347
|
biostudies-literature
Cite
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.
Not available
S-EPMC5961503
|
biostudies-literature
Cite
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.
Not available
S-EPMC5892207
|
biostudies-literature
Cite
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer.
Not available
S-EPMC6326181
|
biostudies-literature
Cite
Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types.
Not available
S-EPMC5916807
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets